URN:NBN:SI:doc-2UBIBGEI2002Janku, Filipdocuments/znanstveni_clanki/radiology_and_oncology/html/urn_nbn_si_doc-2ubibgei.htmldocuments/znanstveni_clanki/radiology_and_oncology/pdf/urn_nbn_si_doc-2ubibgei.pdfdocuments/znanstveni_clanki/radiology_and_oncology/txt/urn_nbn_si_doc-2ubibgei.txt2369 straniarticlestr. 121-1291318-209915184601URN:NBN:SI:doc-2UBIBGEIengAssociation of Radiology and OncologyRadiology and oncology (Ljubljana)BYAnaliza preživetjaAntagonists and inhibitorsbreastBreast neoplasmsDojka, novotvorbedojkeDrug therapyIzid zdravljenjaKarnofsky performance statusKarnofskyva ocena sposobnostiNeoplasm metastasisNovotvorba, metastazanovotvorbeProspective studiesProspektivne študijeProto-oncogene proteins c-erbb-2Survival analysistherapyTreatment outcometumorzdravljenjeEfficacy of weekly trastuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancerthe impact of taxane free interval on treatment outcomes